Basit öğe kaydını göster

dc.contributor.authorKurtoglu, Emel
dc.contributor.authorAvci, Bahattin
dc.contributor.authorKokcu, Arif
dc.contributor.authorCelik, Handan
dc.contributor.authorDura, Mustafa Cengiz
dc.contributor.authorMalatyalioglu, Erdal
dc.contributor.authorOzdemir, Ayse Zehra
dc.date.accessioned2020-06-21T13:32:56Z
dc.date.available2020-06-21T13:32:56Z
dc.date.issued2016
dc.identifier.issn1476-7058
dc.identifier.issn1476-4954
dc.identifier.urihttps://doi.org/10.3109/14767058.2015.1072157
dc.identifier.urihttps://hdl.handle.net/20.500.12712/13289
dc.descriptionAVCI, Bahattin/0000-0001-6471-6495en_US
dc.descriptionWOS: 000373516000022en_US
dc.descriptionPubMed: 26333278en_US
dc.description.abstractObjective: The aim of this study evaluate the value of vascular endothelial growth factor (VEGF) and placental growth factor (PGF) serum levels in prediction of preeclampsia, severity and onset time of the disease.Methods: Twenty five placentas of pregnant women diagnosed with preeclampsia (15 severe preeclampsia, 10 mild preeclampsia) and peripheral venous blood samples were collected. The placental and serum levels of VEGF and PGF were measured.Results: VEGF level was significantly higher in cases and the optimal cut-off point was calculated as 600.5 to differentiate the cases and the controls, with 64% sensitivity and 100% specificity. There was a significant increase in median serum level of VEGF in severe cases compared to the mild cases and the controls. The optimal cut-off point for VEGF was calculated as 673.5 to differentiate mild and severe cases, with 93.3% sensitivity and 90% specificity. Whereas, PGF was significantly lower in severe cases than that in the mild cases and controls. The optimal cut-off point for PGF was calculated as 16.1 to differentiate mild and severe cases, with 66.7% sensitivity and 100% specificity.Conclusion: VEGF and PGF may be significant markers in prediction of severity of preeclampsia, and VEGF may also be valuable in prediction of preeclampsia.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.isversionof10.3109/14767058.2015.1072157en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMaternal serumen_US
dc.subjectplacentaen_US
dc.subjectplacental growth factoren_US
dc.subjectpreeclampsiaen_US
dc.subjectvascular endothelial growth factoren_US
dc.titleSerum VEGF and PGF may be significant markers in prediction of severity of preeclampsiaen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume29en_US
dc.identifier.issue12en_US
dc.identifier.startpage1987en_US
dc.identifier.endpage1992en_US
dc.relation.journalJournal of Maternal-Fetal & Neonatal Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster